C-reactive Protein and Lactate Dehydrogenase Serum Levels Potentially Predict the Response to Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.
JOURNAL OF THORACIC DISEASE(2023)
Key words
Non-small cell lung cancer (NSCLC),checkpoint inhibitors,C-reactive protein (CRP),lactic dehydrogenase (LDH)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined